Welcome to our dedicated page for Veritex Holdings SEC filings (Ticker: VBTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Veritex’s 250-page annual report can feel like wading through footnotes on every loan category in Texas. Credit metrics, net interest margin tables and detailed allowance calculations hide deep inside the fine print—yet those numbers move the stock. If you have ever searched for “Veritex insider trading Form 4 transactions” or wondered which page explains the latest loan loss provision, you know the challenge.
Stock Titan solves that problem in seconds. Our AI parses every “Veritex quarterly earnings report 10-Q filing”, tags risk-weighted asset data and highlights shifts in deposit costs. Click once to see “Veritex Form 4 insider transactions real-time” or get a plain-English brief under the heading “Veritex SEC filings explained simply”. Whether you need “Veritex earnings report filing analysis”, an alert on “Veritex 8-K material events explained”, or help “understanding Veritex SEC documents with AI”, the platform delivers clear context, not jargon.
Bank-specific insight matters. In the “Veritex annual report 10-K simplified” view, you’ll instantly spot changes in commercial real estate exposure. The proxy tab answers “Veritex proxy statement executive compensation” questions, and the insider section tracks every “Veritex executive stock transactions Form 4”. Use AI-generated summaries to:
- Compare quarter-over-quarter net interest margin trends.
- Monitor capital ratios ahead of rate shifts.
- See director buying minutes after a filing posts.
With comprehensive coverage, real-time EDGAR updates, and expert commentary tailored to community banking, Stock Titan turns Veritex’s complex disclosures into actionable clarity.
Form 4 overview – Workday, Inc. (WDAY)
On 07/01/2025 company co-founder, director and >10% owner David A. Duffield reported a conversion of 72,917 Class B shares into Class A shares, immediately followed by open-market sales of exactly the same amount of Class A common stock. The transactions were executed under a pre-existing Rule 10b5-1 trading plan dated 12/03/2024.
- Conversion (Code C): 72,917 Class B → Class A shares, stated price $0.
- Sales (Code S): 72,917 Class A shares disposed in five blocks at weighted-average prices ranging from $237.10 to $240.78 per share.
- Estimated gross proceeds: roughly $17.4 million based on the per-block prices and share counts disclosed.
- Remaining ownership: 102,997 Class A shares held directly, 30,000 Class A shares held indirectly through the Dave & Cheryl Duffield Foundation, and 41,993,734 Class B shares held directly via the David A. Duffield Trust.
- Class B shares retain super-voting rights but are fully convertible into Class A on a 1-for-1 basis and carry no expiration date, subject to the automatic conversion provisions described in footnotes 8-9.
After the reported transactions, Duffield’s economic and voting interest in Workday remains overwhelmingly intact; the sale represents <1% of his total Class B holdings. Because the disposals were made under a 10b5-1 plan, timing concerns are mitigated, yet the activity still constitutes insider selling that investors may monitor as part of sentiment analysis.
Veritex Holdings, Inc. (VBTX) filed a Form 4 disclosing insider transactions by Chief Financial Officer Terry Earley. The filing covers activity on July 1, 2025, one day after Earley’s retirement became effective (June 30, 2025).
- Vesting/Conversion (Code M): 97,204 restricted stock units (RSUs) automatically vested and converted into common shares at a $0 exercise price, reflecting retirement-based acceleration.
- Tax Withholding Sale (Code F): 42,485 shares were disposed of at $26.87 per share to satisfy withholding obligations.
- Post-transaction ownership: Earley now holds 245,259 direct shares and 8,286 indirect shares (IRA), for a total beneficial ownership of 253,545 shares.
The net effect is an increase of roughly 54,700 directly held shares, signalling that the retiring executive retains a sizable equity stake. No derivative securities remain outstanding after the RSU conversion.
While the filing confirms Earley’s retirement and updated ownership, it does not address succession plans or strategic impacts. Investors typically view large insider holdings as alignment of interests, but the departure of a key financial executive can introduce short-term governance and continuity questions.
Veritex Holdings, Inc. (VBTX) has filed a Form S-8 to register up to 1,650,000 additional shares of its $0.01 par value common stock for issuance under employee equity plans. The filing covers (i) 750,000 shares tied to outstanding awards granted under the shareholder-approved 2022 Amended and Restated Omnibus Incentive Plan and (ii) 900,000 newly authorized shares available under the recently approved 2025 Amended and Restated Omnibus Incentive Plan.
The 2025 Plan, adopted by the board on 25 Apr 2025 and ratified by shareholders on 27 May 2025, amends and restates the 2022 Plan and further expands the company’s long-term incentive capacity. Earlier plans included the 2014 Plan (1 million shares) and the 2019 Plan (1.5 million shares).
No proceeds flow directly to the company at the time of registration; actual cash inflow, if any, will occur upon option exercise or settlement of awards for cash. The filing reiterates Texas law–based indemnification provisions for directors and officers and lists customary undertakings required by the Securities Act.
For investors, the key consideration is the potential dilution from issuing up to 1.65 million additional shares, offset by the strategic objective of aligning management and employee incentives with shareholder interests. The impact magnitude will depend on Veritex’s total shares outstanding and the pace at which awards vest or are exercised.
Omeros Corporation (OMER) filed a Form 4 disclosing that non-employee director Dr. Leroy E. Hood received an annual stock-option grant for 15,000 shares on 27 Jun 2025. The option carries a $3.20 exercise price, a 10-year term expiring 27 Jun 2035, and will vest in full the day before the 2026 annual shareholder meeting provided he remains a director. No open-market purchases or sales of common stock were reported, and Table I shows no change in non-derivative share ownership. The filing reflects routine director compensation and represents a negligible portion of Omeros’ total shares outstanding, implying minimal immediate dilution or market impact.